Med-Pro: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Med-Pro
Largest movements
- Cash -€1,553
down €1,553 (-41.2%), from €3,772 to €2,219
mainly Net result for the year (-€3,394)
- Profit (loss) carried forward -€3,394
down €3,394 (-58.8%), from -€5,771 to -€9,165
- Trade debts +€1,696
up €1,696 (+5.4%), from €31,614 to €33,310
- Gross operating margin -€1,443
down €1,443 (-93.2%), from -€1,548 to -€2,991
- Other operating charges -€321
down €321 (-50.6%), from €634 to €313
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €50,843 | €49,145 | -€1,698 | -3.3% |
| Current assets | 29/58 | €50,843 | €49,145 | -€1,698 | -3.3% |
| Amounts receivable within one year | 40/41 | €47,072 | €46,926 | -€145 | -0.3% |
| Trade receivables | 40 | €1,847 | €1,847 | = | 0.0% |
| Other amounts receivable | 41 | €45,224 | €45,079 | -€145 | -0.3% |
| Cash at bank and in hand | 54/58 | €3,772 | €2,219 | -€1,553 | -41.2% |
| Total equity and liabilities | 10/49 | €50,843 | €49,145 | -€1,698 | -3.3% |
| Equity | 10/15 | €19,229 | €15,835 | -€3,394 | -17.6% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Outside capital | 11 | €25,000 | €25,000 | = | 0.0% |
| Other | 1109/19 | €25,000 | €25,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€5,771 | -€9,165 | -€3,394 | -58.8% |
| Amounts payable | 17/49 | €31,614 | €33,310 | +€1,696 | +5.4% |
| Amounts payable within one year | 42/48 | €31,614 | €33,310 | +€1,696 | +5.4% |
| Trade debts | 44 | €31,614 | €33,310 | +€1,696 | +5.4% |
| Suppliers | 440/4 | €31,614 | €33,310 | +€1,696 | +5.4% |
| Other operating charges | 640/8 | €634 | €313 | -€321 | -50.6% |
| Gross operating margin | 9900 | -€1,548 | -€2,991 | -€1,443 | -93.2% |
| Operating profit (loss) | 9901 | -€2,182 | -€3,304 | -€1,122 | -51.4% |
| Financial charges | 65/66B | €104 | €90 | -€14 | -13.8% |
| Recurring financial charges | 65 | €104 | €90 | -€14 | -13.8% |
| Profit (loss) for the period before taxes | 9903 | -€2,286 | -€3,394 | -€1,107 | -48.4% |
| Profit (loss) for the period | 9904 | -€2,286 | -€3,394 | -€1,107 | -48.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,286 | -€3,394 | -€1,107 | -48.4% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.